{"title": "HHS, DOD award $481M for point-of-care COVID-19 test, announce vaccine manufacturer partnership | AHA News", "author": "Tjordan Drupal", "url": "https://www.aha.org/news/headline/2020-10-14-hhs-dod-award-481m-point-care-covid-19-test-announce-vaccine-manufacturer", "hostname": "aha.org", "description": "The Department of Health and Human Services and the Department of Defense awarded $481 million to Cue Health Inc. to expand production of a point-of-care COVID-19 molecular test with capabilities to produce results in 20 minutes.", "sitename": "American Hospital Association | AHA News", "date": "2020-10-14", "cleaned_text": "HHS, DOD award $481M for point-of-care COVID-19 test, announce vaccine manufacturer partnership The Department of Health and Human Services and the Department of Defense [yesterday awarded](https://www.hhs.gov/about/news/2020/10/13/trump-administration-makes-major-investment-to-increase-availability-of-fast-molecular-poc-test.html) $481 million to Cue Health Inc. to expand production of a point-of-care COVID-19 molecular test with capabilities to produce results in 20 minutes. Cue said the highly sensitive test uses a nasal swab sample to detect RNA of SARS-CoV-2, the virus that causes COVID-19. HHS said the partnership allows Cue to increase production to 100,000 test kits per day by March 2021. Also yesterday, HHS and DOD announced [a separate, $31 million agreement](https://www.hhs.gov/about/news/2020/10/13/trump-administration-expands-manufacturing-capacity-cytiva-components-covid-19-vaccines.html) with Cytiva to expand the company's capacity to produce items essential to the production of COVID-19 vaccines such as liquid and dry powder cell culture media, cell culture buffers, "}